Mair Therapeutics and Radboud University Team Up to Tackle Parkinson's with TMEM175 Agonists Mair Therapeutics collaborates with Radboud University to explore TMEM175 agonists that could represent a breakthrough in Parkinson's disease treatment.

Mair Therapeutics and Radboud University Team Up to Tackle Parkinson's with TMEM175 Agonists #Netherlands #Nijmegen #Mair_Therapeutics #Radboud_University #TMEM175